Leptomeningeal metastasis of HER2-positive breast cancer

Clinical trials for Leptomeningeal metastasis of HER2-positive breast cancer explained in plain language.

Never miss a new study

Get alerted when new Leptomeningeal metastasis of HER2-positive breast cancer trials appear

Sign up with your email to follow new studies for Leptomeningeal metastasis of HER2-positive breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy targets breast cancer cells in the brain

Disease control Recruiting now

This study tests whether giving two drugs directly into the spinal fluid can shrink or control breast cancer that has spread to the lining of the brain. It is for people with HER2-positive breast cancer. The drugs are given through a small device placed under the scalp. The goal …

Matched conditions: LEPTOMENINGEAL METASTASIS OF HER2-POSITIVE BREAST CANCER

Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC

Leptomeningeal metastasis of HER2-positive breast cancer

Get alerted when new Leptomeningeal metastasis of HER2-positive breast cancer trials appear

New combo therapy targets breast cancer cells in the brain